| Literature DB >> 7360486 |
J Rubin, D A Decker, D L Ahmann, R T Eagan, J N Ingle, R G Hahn.
Abstract
A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7360486 DOI： 10.1159/000225424
Source DB: PubMed Journal: Oncology ISSN： 0030-2414 Impact factor: 2.935